Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Stoke Therapeutics, Inc. STOK

Full chart Compare
Set alert

Price alert · STOK

All alert types
27.45 USD +0.46 (+1.70%)

At closeNov 4, 2026, 5:03 PM EST

27.45 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

26.60 Day range 27.75
20.32 52-week range 40.22
YTD
-13.52%
1 year
+8.33%

Financial health

Altman Z-Score

16.02 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -265×
FY 2017: -107×FY 2018: -48.2×FY 2019: -17.8×FY 2020: -39.7×FY 2021: -10.3×FY 2022: -3.5×FY 2023: -2.2×FY 2024: -6.7×FY 2025: -265×
FY 2017 5y median -6.7× FY 2025
P/S 10.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 28.9×FY 2023: 26.4×FY 2024: 16.3×FY 2025: 10.2×
FY 2017 5y median 16.3× FY 2025
P/B 5.3×
FY 2017: -465×FY 2018: 5.7×FY 2019: 2.3×FY 2020: 7.2×FY 2021: 4.0×FY 2022: 1.9×FY 2023: 1.5×FY 2024: 2.6×FY 2025: 5.3×
FY 2017 5y median 2.6× FY 2025
P/FCF 41.8×
FY 2017: -109×FY 2018: -50.5×FY 2019: -15.6×FY 2020: -47.9×FY 2021: -12.9×FY 2022: -10.0×FY 2023: -2.8×FY 2024: -6.8×FY 2025: 41.8×
FY 2017 5y median -6.8× FY 2025
EV/EBITDA -352×
FY 2017: -111×FY 2018: -39.5×FY 2019: -9.0×FY 2020: -34.8×FY 2021: -8.7×FY 2022: -2.5×FY 2023: -0.4×FY 2024: -5.4×FY 2025: -352×
FY 2017 5y median -5.4× FY 2025
EV/Sales 9.8×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 20.0×FY 2023: 4.8×FY 2024: 12.9×FY 2025: 9.8×
FY 2017 5y median 9.8× FY 2025
FCF Yield 2.4%
FY 2017: -0.9%FY 2018: -2.0%FY 2019: -6.4%FY 2020: -2.1%FY 2021: -7.7%FY 2022: -10.0%FY 2023: -35.7%FY 2024: -14.6%FY 2025: 2.4%
FY 2017 5y median -10.0% FY 2025

Profitability

Gross Margin 100.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin -11.2%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -841.2%FY 2023: -1307.2%FY 2024: -277.3%FY 2025: -11.2%
FY 2017 5y median -277.3% FY 2025
Net Margin -3.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -814.7%FY 2023: -1192.5%FY 2024: -243.4%FY 2025: -3.7%
FY 2017 5y median -243.4% FY 2025
ROE -2.0%
FY 2017: 430.2%FY 2018: -11.9%FY 2019: -14.4%FY 2020: -18.3%FY 2021: -39.4%FY 2022: -54.7%FY 2023: -65.6%FY 2024: -38.9%FY 2025: -2.0%
FY 2017 5y median -39.4% FY 2025
ROIC -5.7%
FY 2017: -322.2%FY 2018: -12.2%FY 2019: -15.9%FY 2020: -18.4%FY 2021: -38.6%FY 2022: -46.0%FY 2023: -57.5%FY 2024: -43.4%FY 2025: -5.7%
FY 2017 5y median -43.4% FY 2025
ROA -1.6%
FY 2017: -227.9%FY 2018: -11.6%FY 2019: -14.1%FY 2020: -17.5%FY 2021: -35.9%FY 2022: -39.5%FY 2023: -45.9%FY 2024: -32.8%FY 2025: -1.6%
FY 2017 5y median -35.9% FY 2025

Growth (YoY)

Revenue 404.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -29.2%FY 2024: 316.3%FY 2025: 404.5%
FY 2017 FY 2025
Operating Income 79.7%
FY 2017: 0.0%FY 2018: -130.1%FY 2019: -179.1%FY 2020: -48.7%FY 2021: -62.3%FY 2022: -21.3%FY 2023: -10.0%FY 2024: 11.7%FY 2025: 79.7%
FY 2017 FY 2025
EPS (diluted) 92.7%
FY 2017: 0.0%FY 2018: -120.8%FY 2019: -200.0%FY 2020: 1.9%FY 2021: -50.0%FY 2022: -11.1%FY 2023: 8.5%FY 2024: 30.7%FY 2025: 92.7%
FY 2017 FY 2025
Free Cash Flow 151.6%
FY 2017: 0.0%FY 2018: -116.5%FY 2019: -174.7%FY 2020: -32.4%FY 2021: -57.4%FY 2022: 47.4%FY 2023: -130.8%FY 2024: -5.3%FY 2025: 151.6%
FY 2017 FY 2025

Financial Health

Current Ratio 5.3×
FY 2017: 0.5×FY 2018: 43.0×FY 2019: 55.1×FY 2020: 25.7×FY 2021: 13.4×FY 2022: 7.8×FY 2023: 7.0×FY 2024: 5.8×FY 2025: 5.3×
FY 2017 5y median 7.0× FY 2025
Quick Ratio 5.3×
FY 2017: 0.5×FY 2018: 43.0×FY 2019: 55.1×FY 2020: 25.7×FY 2021: 13.4×FY 2022: 7.8×FY 2023: 7.0×FY 2024: 5.8×FY 2025: 5.3×
FY 2017 5y median 7.0× FY 2025
Debt / Equity 0.0×
FY 2017: -2.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 15.9×
FY 2017: -0.2×FY 2018: 8.4×FY 2019: 7.0×FY 2020: 5.6×FY 2021: 1.6×FY 2022: 1.1×FY 2023: 1.9×FY 2024: 1.4×FY 2025: 15.9×
FY 2017 5y median 1.6× FY 2025
Interest Coverage -2288×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -2288×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31